Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study

NCT06368856 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Healthy
Staphylococcus Aureus Infection

Interventions

DRUG: Mupirocin (50 mg)
DRUG: Mupirocin (500 mg)
BIOLOGICAL: blood samples after Single dose part
DIAGNOSTIC_TEST: nasal swab after Single dose part
OTHER: Collection of urine after Single dose part
DIAGNOSTIC_TEST: nasal swab during Repeated dose part
OTHER: Collection of urine during Repeated dose part
OTHER: nasal swab after Repeated dose part

Sponsor

Centre Hospitalier Universitaire de Saint Etienne